Breast Cancer Action’s March newsletter (#100, congratulations!) covers why it’s so difficult to alter reliance on certain breast cancer treatments — even when there’s evidence to indicate the drug is not working.
Two factors cited by BCA Executive Director Barbara Brenner are longstanding attitudes about the best way to treat cancer (read: aggressively) and the pharmaceutical industry’s investment in particular drugs.
“Given this training, doctors probably fear giving up on a treatment that they think might help some patients,” writes Brenner. “Making a mistake could … Read